Zhu_2022_BMC.Cardiovasc.Disord_22_481

Reference

Title : The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation - Zhu_2022_BMC.Cardiovasc.Disord_22_481
Author(s) : Zhu Z , Qian C , Su C , Tao H , Mao J , Guo Z , Zhu X , Pan J
Ref : BMC Cardiovasc Disord , 22 :481 , 2022
Abstract : Zhu_2022_BMC.Cardiovasc.Disord_22_481
ESTHER : Zhu_2022_BMC.Cardiovasc.Disord_22_481
PubMedSearch : Zhu_2022_BMC.Cardiovasc.Disord_22_481
PubMedID: 36368930

Related information

Citations formats

Zhu Z, Qian C, Su C, Tao H, Mao J, Guo Z, Zhu X, Pan J (2022)
The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation
BMC Cardiovasc Disord 22 :481

Zhu Z, Qian C, Su C, Tao H, Mao J, Guo Z, Zhu X, Pan J (2022)
BMC Cardiovasc Disord 22 :481